A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
EpiBiologics
EpiBiologics
Radiopharm Theranostics, Ltd
Qilu Pharmaceutical Co., Ltd.
Onchilles Pharma Inc
Regeneron Pharmaceuticals
OncoHost Ltd.
Shanghai Bao Pharmaceuticals Co., Ltd.
Cellid Co., Ltd.
SUNHO(China)BioPharmaceutical CO., Ltd.
Alpha Tau Medical LTD.